Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 May 28;7(4):e759.
doi: 10.1212/NXI.0000000000000759. Print 2020 Jul.

Are aquaporin antibody titers useful outcome measures for neuromyelitis optica spectrum disorders?

Markus Reindl  1
Affiliations
Editorial

Are aquaporin antibody titers useful outcome measures for neuromyelitis optica spectrum disorders?

Markus Reindl. Neurol Neuroimmunol Neuroinflamm. .
No abstract available

PubMed Disclaimer

Comment in

  • Clinical utility of AQP4-IgG titers and measures of complement-mediated cell killing in NMOSD.
    Jitprapaikulsan J, Fryer JP, Majed M, Smith CY, Jenkins SM, Cabre P, Hinson SR, Weinshenker BG, Mandrekar J, Chen JJ, Lucchinetti CF, Jiao Y, Segan J, Schmeling JE, Mills J, Flanagan EP, McKeon A, Pittock SJ. Jitprapaikulsan J, et al. Neurol Neuroimmunol Neuroinflamm. 2020 May 28;7(4):e727. doi: 10.1212/NXI.0000000000000727. Print 2020 Jul. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 35413004 Free PMC article.

References

    1. Wingerchuk DM, Banwell B, Bennett JL, et al. . International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85:177–189. - PMC - PubMed
    1. Hartung HP, Aktas O. Old and new breakthroughs in neuromyelitis optica. Lancet Neurol 2020;19:280–281. - PubMed
    1. Takahashi T, Fujihara K, Nakashima I, et al. . Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007;130:1224–1234. - PubMed
    1. Jarius S, Aboul-Enein F, Waters P, et al. . Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 2008;131:3072–3080. - PMC - PubMed
    1. Jitprapaikulsan J, Fryer J, Majed M, et al. . Clinical utility of AQP4-IgG titers and measures of complement-mediated cell killing in NMOSD. Neurol Neuroimmunol Neuroinflamm 2020;7:e727. doi: 10.1212/NXI.0000000000000727. - DOI - PMC - PubMed

Publication types